1. Home
  2. ATYR vs BNED Comparison

ATYR vs BNED Comparison

Compare ATYR & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • BNED
  • Stock Information
  • Founded
  • ATYR 2005
  • BNED 1965
  • Country
  • ATYR United States
  • BNED United States
  • Employees
  • ATYR N/A
  • BNED N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • BNED Other Specialty Stores
  • Sector
  • ATYR Health Care
  • BNED Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • BNED Nasdaq
  • Market Cap
  • ATYR 330.7M
  • BNED 310.9M
  • IPO Year
  • ATYR 2015
  • BNED N/A
  • Fundamental
  • Price
  • ATYR $3.87
  • BNED $9.72
  • Analyst Decision
  • ATYR Strong Buy
  • BNED Hold
  • Analyst Count
  • ATYR 6
  • BNED 1
  • Target Price
  • ATYR $18.60
  • BNED N/A
  • AVG Volume (30 Days)
  • ATYR 2.1M
  • BNED 400.2K
  • Earning Date
  • ATYR 03-13-2025
  • BNED 03-10-2025
  • Dividend Yield
  • ATYR N/A
  • BNED N/A
  • EPS Growth
  • ATYR N/A
  • BNED N/A
  • EPS
  • ATYR N/A
  • BNED N/A
  • Revenue
  • ATYR $235,000.00
  • BNED $1,567,800,000.00
  • Revenue This Year
  • ATYR $1,387.23
  • BNED $2.74
  • Revenue Next Year
  • ATYR $873.22
  • BNED N/A
  • P/E Ratio
  • ATYR N/A
  • BNED N/A
  • Revenue Growth
  • ATYR N/A
  • BNED N/A
  • 52 Week Low
  • ATYR $1.42
  • BNED $6.05
  • 52 Week High
  • ATYR $4.66
  • BNED $135.00
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 54.43
  • BNED 49.56
  • Support Level
  • ATYR $2.98
  • BNED $8.16
  • Resistance Level
  • ATYR $4.32
  • BNED $10.17
  • Average True Range (ATR)
  • ATYR 0.41
  • BNED 0.63
  • MACD
  • ATYR 0.06
  • BNED 0.09
  • Stochastic Oscillator
  • ATYR 72.14
  • BNED 77.81

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: